09 February 2010, London, UK and Cambridge, MA: - Antisoma plc (LSE: ASM; USOTC:
ATSMY) will be announcing its interim results for the six months ended 31
December 2009 on Thursday 18 February 2010.
Senior Marketing and Communications Executive
+44 (0)20 3249 2144
Mark Court/Lisa Baderoon/Rebecca Skye Dietrich
+44 (0)20 7466 5000
Background on Antisoma
Antisoma is a London Stock Exchange-listed biopharmaceutical company that
develops novel products for the treatment of cancer. The Company has operations
in the UK and the US. Please visitwww.antisoma.com <
further information about Antisoma.